Mint Tower Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Mint Tower Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-790	Closed	-$54K	–	611
2022 Q3	$54K	Buy	+790	New	+$43.6K	﹤0.01%	414

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mint Tower Capital Management's GBT Position: Q4 2022 in Review

Mint Tower Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 790 shares — an estimated $54K sold.

Mint Tower Capital Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $54K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Mint Tower Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Mint Tower Capital Management sold 790 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $54K.
Mint Tower Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Mint Tower Capital Management's Global Blood Therapeutics, Inc. position peaked at $54K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Mint Tower Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.